Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) shares rose 1.3% during trading on Tuesday . The company traded as high as $2.45 and last traded at $2.37. Approximately 7,693 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $2.34.
Ampliphi Biosciences Stock Down 3.6 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Read More
- Five stocks we like better than Ampliphi Biosciences
- Energy and Oil Stocks Explained
- Advance Auto Parts Eyes Long-Term Growth Despite Q2 Hurdles
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Toll Brothers Stock Up on Q3 Beat: Luxury Homes Drive Growth
- What are earnings reports?
- 4 No-Brainer Stocks to Hold This Fall for Steady Gains
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
